ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!JAGX Company Profile and Key Details
Jaguar Health, Inc.
JAGX Stock Price Chart
Stock Price Today
Jaguar Health, Inc. (JAGX) stock declined over -2.86%, trading at $0.86 on NASDAQ, down from the previous close of $0.88. The stock opened at $0.92, fluctuating between $0.86 and $0.92 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.
Company Information
| Employees | 49 |
| Beta | 0.85 |
| Sales or Revenue | $9.76M |
| 5Y Sales Change% | -0.988% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Jaguar Health, Inc. (NASDAQ: JAGX) stock price is $0.86 in the last trading session. During the trading session, JAGX stock reached the peak price of $0.92 while $0.86 was the lowest point it dropped to. The percentage change in JAGX stock occurred in the recent session was -2.86% while the dollar amount for the price change in JAGX stock was -$0.03.
The NASDAQ listed JAGX is part of Biotechnology industry that operates in the broader Healthcare sector. Jaguar Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. David Sesin
Chief Manufacturing Officer
Dr. Michael K. Guy D.V.M., M.S., Ph.D.
Vice President of Preclinical & Nonclinical Studies
Ms. Carol R. Lizak
Chief Financial Officer
Mr. Jonathan S. Wolin C.P.A., J.D., M.B.A.
Chief of Staff, Chief Compliance Officer & Gen. Counsel
Ms. Lisa A. Conte
Founder, Chief Executive Officer, Pres & Director
Dr. Pravin R. Chaturvedi Ph.D.
Chief Scientific Officer & Chair of Scientific Advisory Board
Mr. Jonathan S. Wolin CPA, J.D., M.B.A.
Chief of Staff, Chief Compliance Officer & Gen. Counsel
Mr. Ian H. Wendt M.B.A.
Chief Commercial Officer
Dr. Steven R. King Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
Ms. Carol R. Lizak M.B.A.
Chief Financial Officer
Mr. Peter Hodge
Senior Director of Investor Relations, Bus. Devel. & Special Events
Dr. Karen J. Brunke Ph.D.
Executive Vice President of Corporation & Bus. Devel.
JAGX's closing price is 9.9% higher than its 52-week low of $0.78 where as its distance from 52-week high of $21.60 is -96.04%.
Number of JAGX employees currently stands at 49.
Official Website of JAGX is: https://jaguar.health
JAGX could be contacted at phone 415 371 8300 and can also be accessed through its website. JAGX operates from 200 Pine Street, San Francisco, CA 94104, United States.
JAGX stock volume for the day was 116.52K shares. The average number of JAGX shares traded daily for last 3 months was 455.8K.
The market value of JAGX currently stands at $13.96M with its latest stock price at $0.86 and 16.31M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com